Summary:
Click image to enlargeGAIN is a clinical trial evaluating whether an investigational oral drug is safe and can halt the progression of Alzheimer’s disease by reducing the damage caused by bacteria in the brain.
Qualified Participants Must:
• Be 55-80 years old
• Have been diagnosed with mild to moderate Alzheimer's disease
• Have a caregiver or family member who will attend study visits, report on daily activities and oversee you taking medication
Qualified Participants May Receive:
Qualified participants may receive study-related care and study drug at no cost. Compensation may be available as well.